[Enhancing effect of reserpine upon the cytotoxicity of ACNU on ACNU-resistant glioma cells].

نویسندگان

  • T Yoshida
  • K Shimizu
  • Y Ushio
  • T Hayakawa
  • H Mogami
  • Y Sakamoto
چکیده

Reserpine has enhanced the cytotoxicity of 1 (4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2 chloroethyl)-3-nitrosourea hydrochloride (ACNU) in both ACNU-resistant sublines of C6 and 9L glioma cells (C6/ACNU, 9L/ACNU) and could completely overcome ACNU resistance in vitro. When reserpine was added to the culture in the concentration of 10ƒÊM, the concentrations of drug required for 50% inhibition of cell growth of ACNU for C6/ACNU and 9L/ACNU cells decreased to the level of those for C6 and 9L cells, respectively. Intracellular uptake and retention of ACNU in both ACNU-resistant cells increased when 20ƒÊM reserpine was added to the culture. It is suggested that the enhanced effect of cytotoxicity of ACNU in ACNU-resistant glioma cells is presumably due to the increase of intracellular concentration of ACNU through the inhibition of the efflux of intra cellular ACNU from resistant cells.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice

Nimustine (ACNU) has antitumor activities in patients with malignant glioma. Hyperbaric oxygen (HBO) may enhance the efficacy of certain therapies that are hampered by the hypoxic microenvironment. We examined the combined effects of ACNU and HBO in a GFP transgenic nude mice bearing human glioma model. Mice inoculated with human glioma cells SU3 were randomly divided into the four groups: (A) ...

متن کامل

Anti-vascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenografts.

We evaluated the effectiveness of vascular endothelial growth factor (VEGF) blockade alone and in combination with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU, nimustine), a cytotoxic agent commonly used in the treatment of malignant gliomas, to eradicate tumors of human glioblastoma cell lines implanted in SCID (severe combined immunodeficiency) mice. ACNU, b...

متن کامل

Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.

Glioblastoma multiforme is the most severe form of brain cancer. First line therapy includes the methylating agent temozolomide and/or the chloroethylating nitrosoureas [1-(2-chloroethyl)-1-nitrosourea; CNU] nimustine [1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea; ACNU], carmustine [1,3-bis(2-chloroethyl)-1-nitrosourea; BCNU], or lomustine [1-(2-chloroethyl)-3-cycloh...

متن کامل

Modes of actions of two types of anti-neoplastic drugs, dacarbazine and ACNU, to induce apoptosis.

O(6)-Methylguanine and O(6)-chloroethylguanine, which are the primary cytotoxic DNA lesions produced by 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (dacarbazine) and 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU), respectively, can be repaired by O(6)-methylguanine-DNA methyltransferase (MGMT), coded by the MGMT gene. However, the two types of drugs exhib...

متن کامل

Apoptosis induced by temozolomide and nimustine in glioblastoma cells is supported by JNK/c-Jun-mediated induction of the BH3-only protein BIM

The outcome of cancer therapy strongly depends on the complex network of cell signaling pathways, including transcription factor activation following drug exposure. Here we assessed whether and how the MAP kinase (MAPK) cascade and its downstream target, the transcription factor AP-1, influence the sensitivity of malignant glioma cells to the anticancer drugs temozolomide (TMZ) and nimustine (A...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Neurologia medico-chirurgica

دوره 26 12  شماره 

صفحات  -

تاریخ انتشار 1986